R, Q., F, A., & A, K. (2026). Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions. Molecular diagnosis & therapy, 30(2), 321. https://doi.org/10.1007/s40291-026-00833-w
Chicago Style (17th ed.) CitationR, Qaisar, Ahmad F, and Karim A. "Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions." Molecular Diagnosis & Therapy 30, no. 2 (2026): 321. https://doi.org/10.1007/s40291-026-00833-w.
MLA (9th ed.) CitationR, Qaisar, et al. "Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions." Molecular Diagnosis & Therapy, vol. 30, no. 2, 2026, p. 321, https://doi.org/10.1007/s40291-026-00833-w.